Aberrant Excitatory–Inhibitory Synaptic Mechanisms in Entorhinal Cortex Microcircuits During the Pathogenesis of Alzheimer’s Disease

Abstract Synaptic dysfunction is widely proposed as an initial insult leading to the neurodegeneration observed in Alzheimer’s disease (AD). We hypothesize that the initial insult originates in the lateral entorhinal cortex (LEC) due to deficits in key interneuronal functions and synaptic signaling mechanisms, in particular, Wnt (Wingless/integrated). To investigate this hypothesis, we utilized the first knock-in mouse model of AD (AppNL-F/NL-F), expressing a mutant form of human amyloid-β (Aβ) precursor protein. This model shows an age-dependent accumulation of Aβ, neuroinflammation, and neurodegeneration. Prior to the typical AD pathology, we showed a decrease in canonical Wnt signaling activity first affecting the LEC in combination with synaptic hyperexcitation and severely disrupted excitatory–inhibitory inputs onto principal cells. This synaptic imbalance was consistent with a reduction in the number of parvalbumin-containing (PV) interneurons, and a reduction in the somatic inhibitory axon terminals in the LEC compared with other cortical regions. However, targeting GABAA receptors on PV cells using allosteric modulators, diazepam, zolpidem, or a nonbenzodiazepine, L-838,417 (modulator of α2/3 subunit-containing GABAA receptors), restored the excitatory–inhibitory imbalance observed at principal cells in the LEC. These data support our hypothesis, providing a rationale for targeting the synaptic imbalance in the LEC for early stage therapeutic intervention to prevent neurodegeneration in AD.

[1]  N. Inestrosa,et al.  Loss of canonical Wnt signaling is involved in the pathogenesis of Alzheimer's disease , 2018, Neural regeneration research.

[2]  A. I. Rojo,et al.  A role for APP in Wnt signalling links synapse loss with β-amyloid production , 2018, Translational Psychiatry.

[3]  K. Novak,et al.  Evidence of Wnt/β-catenin alterations in brain and bone of a tauopathy mouse model of Alzheimer's disease , 2018, Neurobiology of Aging.

[4]  M. Duchen,et al.  Diazepam-induced loss of inhibitory synapses mediated by PLCδ/ Ca2+/calcineurin signalling downstream of GABAA receptors , 2018, Molecular Psychiatry.

[5]  P. Xing,et al.  The Role of Fluoxetine in Activating Wnt/β-Catenin Signaling and Repressing β-Amyloid Production in an Alzheimer Mouse Model , 2018, Front. Aging Neurosci..

[6]  M. Walker,et al.  Cannabidiol exerts antiepileptic effects by restoring hippocampal interneuron functions in a temporal lobe epilepsy model , 2018, British journal of pharmacology.

[7]  J. Wu,et al.  Synaptic mechanism in Alzheimer’s disease: a selective degeneration of an excitatory synaptic pathway in the CA1 hippocampus that controls spatial learning and memory in Alzheimer’s disease , 2018, Molecular Psychiatry.

[8]  N. Inestrosa,et al.  Wnt signaling loss accelerates the appearance of neuropathological hallmarks of Alzheimer's disease in J20‐APP transgenic and wild‐type mice , 2018, Journal of neurochemistry.

[9]  X. Liang,et al.  Sodium selenate activated Wnt/β-catenin signaling and repressed amyloid-β formation in a triple transgenic mouse model of Alzheimer's disease , 2017, Experimental Neurology.

[10]  Jason C. Wester,et al.  Hippocampal GABAergic Inhibitory Interneurons. , 2017, Physiological reviews.

[11]  B. Winblad,et al.  APP mouse models for Alzheimer's disease preclinical studies , 2017, The EMBO journal.

[12]  Kei M. Igarashi,et al.  Impaired In Vivo Gamma Oscillations in the Medial Entorhinal Cortex of Knock-in Alzheimer Model , 2017, Front. Syst. Neurosci..

[13]  J. Isaac,et al.  Altered Synapse Stability in the Early Stages of Tauopathy , 2017, Cell reports.

[14]  E. Boyden,et al.  Gamma frequency entrainment attenuates amyloid load and modifies microglia , 2016, Nature.

[15]  L. Mucke,et al.  Network abnormalities and interneuron dysfunction in Alzheimer disease , 2016, Nature Reviews Neuroscience.

[16]  S. Itohara,et al.  Cognitive deficits in single App knock-in mouse models , 2016, Neurobiology of Learning and Memory.

[17]  F. Cacucci,et al.  Reversal of Synapse Degeneration by Restoring Wnt Signaling in the Adult Hippocampus , 2016, Current Biology.

[18]  N. Inestrosa,et al.  Inhibition of Wnt signaling induces amyloidogenic processing of amyloid precursor protein and the production and aggregation of Amyloid‐β (Aβ)42 peptides , 2016, Journal of neurochemistry.

[19]  J. Wu,et al.  A novel mechanism of memory loss in Alzheimer’s disease mice via the degeneration of entorhinal–CA1 synapses , 2016, Molecular Psychiatry.

[20]  Arthur Konnerth,et al.  Impairments of neural circuit function in Alzheimer's disease , 2016, Philosophical Transactions of the Royal Society B: Biological Sciences.

[21]  G. Cox,et al.  Hyperactive Somatostatin Interneurons Contribute to Excitotoxicity in Neurodegenerative Disorders , 2016, Nature Neuroscience.

[22]  N. Inestrosa,et al.  A novel function for Wnt signaling modulating neuronal firing activity and the temporal structure of spontaneous oscillation in the entorhinal–hippocampal circuit , 2015, Experimental Neurology.

[23]  Lief E. Fenno,et al.  Chronic optogenetic activation augments Aβ pathology in a mouse model of Alzheimer disease , 2022 .

[24]  Nazanin Mirzaei,et al.  Activation of the Wnt/β‐catenin pathway represses the transcription of the β‐amyloid precursor protein cleaving enzyme (BACE1) via binding of T‐cell factor‐4 to BACE1 promoter , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[25]  J. Rogers,et al.  Deficiency in LRP6-Mediated Wnt Signaling Contributes to Synaptic Abnormalities and Amyloid Pathology in Alzheimer’s Disease , 2014, Neuron.

[26]  S. Itohara,et al.  Single App knock-in mouse models of Alzheimer's disease , 2014, Nature Neuroscience.

[27]  B. Marchetti,et al.  Regulating Wnt signaling: a strategy to prevent neurodegeneration and induce regeneration. , 2014, Journal of molecular cell biology.

[28]  S. Galli,et al.  Dysfunction of Wnt signaling and synaptic disassembly in neurodegenerative diseases , 2014, Journal of molecular cell biology.

[29]  N. Inestrosa,et al.  Wnt Signaling in the Nervous System and in Alzheimer's Disease Inestrosa and Varela-nallar Inestrosa and Varela-nallar , 2022 .

[30]  Ran Yi,et al.  Krüppel-like Factor 8 Ameliorates Alzheimer's Disease by Activating β-Catenin , 2014, Journal of Molecular Neuroscience.

[31]  R. Mayeux,et al.  Molecular drivers and cortical spread of lateral entorhinal cortex dysfunction in preclinical Alzheimer's disease , 2013, Nature Neuroscience.

[32]  N. Inestrosa,et al.  Wnts in adult brain: from synaptic plasticity to cognitive deficiencies , 2013, Front. Cell. Neurosci..

[33]  P. Salinas,et al.  Wnts in action: from synapse formation to synaptic maintenance , 2013, Front. Cell. Neurosci..

[34]  D. Berwick,et al.  The regulation and deregulation of Wnt signaling by PARK genes in health and disease , 2013, Journal of molecular cell biology.

[35]  Qian-Quan Sun,et al.  Distribution of CaMKIIα expression in the brain in vivo, studied by CaMKIIα-GFP mice , 2013, Brain Research.

[36]  N. Inestrosa,et al.  Wnt signaling: Role in LTP, neural networks and memory , 2013, Ageing Research Reviews.

[37]  T. van Laar,et al.  The APP intracellular domain (AICD) inhibits Wnt signalling and promotes neurite outgrowth. , 2012, Biochimica et biophysica acta.

[38]  K. Shen,et al.  WNTs in synapse formation and neuronal circuitry , 2012, The EMBO journal.

[39]  Amy L. Shelton,et al.  Reduction of Hippocampal Hyperactivity Improves Cognition in Amnestic Mild Cognitive Impairment , 2012, Neuron.

[40]  Edward O. Mann,et al.  Inhibitory Interneuron Deficit Links Altered Network Activity and Cognitive Dysfunction in Alzheimer Model , 2012, Cell.

[41]  Adam W. Bero,et al.  Bidirectional Relationship between Functional Connectivity and Amyloid-β Deposition in Mouse Brain , 2012, The Journal of Neuroscience.

[42]  P. Salinas,et al.  The Secreted Wnt Antagonist Dickkopf-1 Is Required for Amyloid β-Mediated Synaptic Loss , 2012, The Journal of Neuroscience.

[43]  Oscar Marín,et al.  Interneuron dysfunction in psychiatric disorders , 2012, Nature Reviews Neuroscience.

[44]  A. V. Maricq,et al.  Wnt signaling regulates experience-dependent synaptic plasticity in the adult nervous system , 2012, Cell cycle.

[45]  N. Inestrosa,et al.  Regulation of NMDA-Receptor Synaptic Transmission by Wnt Signaling , 2011, The Journal of Neuroscience.

[46]  J. Atack,et al.  GABAA receptor subtype-selective modulators. I. α2/α3-selective agonists as non-sedating anxiolytics. , 2011, Current topics in medicinal chemistry.

[47]  J. Morris,et al.  Alzheimer’s Disease: The Challenge of the Second Century , 2011, Science Translational Medicine.

[48]  C. Grossi,et al.  Lithium Improves Hippocampal Neurogenesis, Neuropathology and Cognitive Functions in APP Mutant Mice , 2010, PloS one.

[49]  A. Verkhratsky.  Physiology of neuronal–glial networking , 2010, Neurochemistry International.

[50]  C. Kilkenny,et al.  Guidelines for reporting experiments involving animals: the ARRIVE guidelines , 2010, British journal of pharmacology.

[51]  R. Sperling,et al.  Longitudinal fMRI in elderly reveals loss of hippocampal activation with clinical decline , 2010, Neurology.

[52]  A. Verkhratsky,et al.  Concomitant astroglial atrophy and astrogliosis in a triple transgenic animal model of Alzheimer's disease , 2010, Glia.

[53]  N. Inestrosa,et al.  Activation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswe/PSEN1ΔE9 mouse model of Alzheimer's disease , 2010, Molecular Psychiatry.

[54]  E. Arenas,et al.  Emerging roles of Wnts in the adult nervous system , 2010, Nature Reviews Neuroscience.

[55]  N. Inestrosa,et al.  Wnt-5a occludes Aβ oligomer-induced depression of glutamatergic transmission in hippocampal neurons , 2010, Molecular Neurodegeneration.

[56]  J. Witton,et al.  Increase in the density of resting microglia precedes neuritic plaque formation and microglial activation in a transgenic model of Alzheimer's disease , 2010, Cell death & disease.

[57]  Isidro Ferrer,et al.  Diminished Perisomatic GABAergic Terminals on Cortical Neurons Adjacent to Amyloid Plaques , 2009, Front. Neuroanat..

[58]  Arthur Konnerth,et al.  Clusters of Hyperactive Neurons Near Amyloid Plaques in a Mouse Model of Alzheimer's Disease , 2008, Science.

[59]  N. Inestrosa,et al.  The role of Wnt signaling in neuronal dysfunction in Alzheimer's Disease , 2008, Molecular Neurodegeneration.

[60]  P. Somogyi,et al.  Neuronal Diversity and Temporal Dynamics: The Unity of Hippocampal Circuit Operations , 2008, Science.

[61]  E. P. Gardner,et al.  Petilla terminology: nomenclature of features of GABAergic interneurons of the cerebral cortex , 2008, Nature Reviews Neuroscience.

[62]  A. Thomson,et al.  Synaptic a 5 Subunit--Containing GABA A Receptors Mediate IPSPs Elicited by Dendrite-Preferring Cells in Rat Neocortex , 2008 .

[63]  Guojun Bu,et al.  Endocytosis Is Required for Synaptic Activity-Dependent Release of Amyloid-β In Vivo , 2008, Neuron.

[64]  R. Rissman,et al.  GABAA receptors in aging and Alzheimer’s disease , 2007, Journal of neurochemistry.

[65]  N. Mirza,et al.  Comparative effects of nonselective and subtype-selective gamma-aminobutyric acidA receptor positive modulators in the rat-conditioned emotional response test , 2007, Behavioural pharmacology.

[66]  P. Érdi,et al.  Pharmacological and computational analysis of alpha-subunit preferential GABAA positive allosteric modulators on the rat septo-hippocampal activity , 2007, Neuropharmacology.

[67]  Dušan Ristanović,et al.  Application of modified Sholl analysis to neuronal dendritic arborization of the cat spinal cord , 2006, Journal of Neuroscience Methods.

[68]  L. Mucke,et al.  A network dysfunction perspective on neurodegenerative diseases , 2006, Nature.

[69]  Jozsef Csicsvari,et al.  Complementary Roles of Cholecystokinin- and Parvalbumin-Expressing GABAergic Neurons in Hippocampal Network Oscillations , 2005, The Journal of Neuroscience.

[70]  Benjamin J. Shannon,et al.  Molecular, Structural, and Functional Characterization of Alzheimer's Disease: Evidence for a Relationship between Default Activity, Amyloid, and Memory , 2005, The Journal of Neuroscience.

[71]  H. Markram,et al.  Interneurons of the neocortical inhibitory system , 2004, Nature Reviews Neuroscience.

[72]  N. Inestrosa,et al.  Wnt-3a overcomes β-amyloid toxicity in rat hippocampal neurons , 2004 .

[73]  J. Lacaille,et al.  Interneuron Diversity series: Hippocampal interneuron classifications – making things as simple as possible, not simpler , 2003, Trends in Neurosciences.

[74]  R. Malinow,et al.  APP Processing and Synaptic Function , 2003, Neuron.

[75]  R. Mckernan,et al.  Density and pharmacology of α5 subunit-containing GABAA receptors are preserved in hippocampus of Alzheimer’s disease patients , 2000, Neuroscience.

[76]  R. Mckernan,et al.  Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABAA receptor α1 subtype , 2000, Nature Neuroscience.

[77]  Y. Kubota,et al.  Correlation of physiological subgroupings of nonpyramidal cells with parvalbumin- and calbindinD28k-immunoreactive neurons in layer V of rat frontal cortex. , 1993, Journal of neurophysiology.

[78]  H. Braak,et al.  Demonstration of Amyloid Deposits and Neurofibrillary Changes in Whole Brain Sections , 1991, Brain pathology.

[79]  Yasuo Kawaguchi,et al.  Fast spiking cells in rat hippocampus (CA1 region) contain the calcium-binding protein parvalbumin , 1987, Brain Research.

[80]  G. Fishell,et al.  Three groups of interneurons account for nearly 100% of neocortical GABAergic neurons , 2011, Developmental neurobiology.